Skip to main
CNCE
CNCE logo

Concert Pharma (CNCE)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Concert Pharma (CNCE) Stock

About Concert Pharma (CNCE)

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on Ap...read more
Market cap$401.95M
Today's volume
Revenue (TTM)
Avg. daily volume2.18M
EBITDA (TTM)
Open
Price / earnings ratio-2.61x
Today's range
Debt / equity
52 week range$2.66 - $8.55
5 year debt / equity9.91x
Beta (LTM)1.06x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 7, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for CNCE stock is $401.95M

The current P/E ratio for CNCE stock is -2.61

The 52-week high for CNCE stock is $8.55. The current CNCE stock price $undefined is 100.00% below its 52-week high

The 52-week low for CNCE stock is $2.66. The current CNCE stock price $undefined has increased 100.00% from its 52-week low

No, the CNCE stock does not pay dividends to its shareholders

How to buy CNCE stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CNCE stock

    Navigate to the Explore page. Then, type CNCE into the search bar. When you see CNCE stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CNCE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Concert Pharma Stock Earnings

The value each CNCE share was expected to gain vs. the value that each CNCE share actually gained.

Concert Pharma (CNCE) reported Q3 2022 earnings per share (EPS) of -$0.58, beating estimates of -$0.59 by 1.69%. In the same quarter last year, Concert Pharma's earnings per share (EPS) was -$0.78. Concert Pharma is expected to release next earnings on 11/07/2022, with an earnings per share (EPS) estimate of $0.

Buy Concert Pharma (CNCE) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.